Tao Zhang
Clinical trials sponsored by Tao Zhang, explained in plain language.
-
New triple therapy aims to control liver-metastatic colorectal cancer in late-stage patients
Disease control Not yet recruitingThis study tests whether a new combination of an antibody drug (QL1706), a targeted therapy (fruquintinib), and short-course radiotherapy can help control advanced colorectal cancer that has spread to the liver and hasn't responded to earlier treatments. About 76 adults aged 18 t…
Phase: PHASE2 • Sponsor: Tao Zhang • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
New combo therapy could boost rectal cancer remission rates
Disease control Not yet recruitingThis study tests if adding immunotherapy to standard treatment (radiation and chemotherapy before surgery) helps more people with high-risk rectal cancer achieve complete remission. It also compares a shorter course of radiation to a longer one. About 435 adults with locally adva…
Phase: PHASE3 • Sponsor: Tao Zhang • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
New drug duo targets hard-to-treat HER2 cancers in groundbreaking trial
Disease control Not yet recruitingThis study tests two drugs, zanidatamab and tislelizumab, together with chemotherapy or radiation for people with HER2-positive gastrointestinal cancers like rectal, stomach, and colon cancer. About 70 adults will receive the treatment to see if it can shrink tumors before surger…
Phase: PHASE2 • Sponsor: Tao Zhang • Aim: Disease control
Last updated May 01, 2026 15:58 UTC